Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...
Pfizer’s Acquisition of Global Blood Therapeutics
Global Blood Therapeutics’ $345 Million Notes Offering
Goodwin Procter advised Global Blood Therapeutics on the deal. Global Blood Therapeutics, Inc. (Nasdaq: GBT) announced its offering of 1.875% Convertible Senior Notes due 2028. The...